The present invention provides a compound of formula (I):
wherein the variants R1, R2, R3, R4, R5, R6, R7 are as defined herein, and wherein said compound is an inhibitor of CETP, and thus can be employed for the treatment of a disorder or disease mediated by CETP or responsive to the inhibition of CETP.
本发明提供了一种化合物,其
化学式为(I):其中变体R1、R2、R3、R4、R5、R6、R7如本文所定义,并且所述化合物是CETP的
抑制剂,因此可用于治疗由CETP介导或对CETP抑制响应的疾病或疾病。